ArticleEBioMedicine2021

Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model.

Pamela C Proud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.